Melissa Ray follows notable TGen officials in key leadership position, keeping Arizona competitive in the global business community

May 18, 2012

Melissa Ray, Director of the Office of Project Management at the Translational Genomics Research Institute (TGen), has been appointed to the Board of Directors of the Arizona Technology Council.

In a statement, the Council described Ray as "forward-thinking and versatile, with 10-plus years of experience driving process and performance improvements for healthcare/biotechnology organizations. She is exceptionally skilled at overseeing quality assurance and policy development activities."

Ray supervises the project managers involved in TGen's scientific investigation of the genetic basis of diseases such as Alzheimer's, diabetes and many types of cancer.

"I am honored to serve on the Board, and I look forward to helping the Council grow Arizona's knowledge-based industries, improve educational opportunities, diversify the state's economic base and generate high-paying jobs in medicine, technology and the biosciences," Ray said.

"Mel's appointment to the Board is recognition of her leadership ascent, both at TGen and in Arizona," said Dr. Michael Berens, Director of TGen's Cancer and Cell Biology Division, as well as Chairman Emeritus of the Arizona Technology Council Board.

"Service by TGen personnel on this statewide organization of leading technology companies is a two-way networking proposition that enriches TGen by strengthening our connections with key partners," said Dr. Berens, who has served on the Council's Board for nearly a decade, including a term as Chairman.

Arizona Technology Council, the voice of Arizona's nearly 500-member technology sector, also announced the appointment of Roger Vogel - Chairman, President and CEO at Vante Medical Technologies - as the Council's Vice Chairman of the Board. Chuck Vermillion, CEO of OneNeck IT Services, remains as Chairman.

The Arizona Technology Council Board represents the interests of Arizona's technology industries and advises the Council in its expressed goals of promoting research, education and access to a highly skilled workforce.

Eight other new directors were also appointed to the Arizona Technology Council Board of Directors at the Board's April 19 meeting. They are: Chad Eckes, CIO of Cancer Treatment Centers of America; Clark Peterson, CEO of Telesphere; Jeff Unruh, Managing Director of Alerion; Mario Martinez II, CEO of 360 Vantage; Tom Maxwell, Engineering Operations Director of Raytheon Missile Systems; Michael Hawksworth, President and CEO of MSS Technologies; Robert Dubberly, a partner of KPMG's Audit Practice, Phoenix; and Anthony Wanger, President of IO.

"The diversity of talent and of the industries that our Board represents provides us with first-class governance," said Steven G. Zylstra, President and CEO of Arizona Technology Council. "This translates into topnotch ideas and wisdom that we will continue to turn into executable programs that benefit all members."

Arizona Technology Council's world-class Executive Officers and Board of Directors serve in an advisory and fiduciary role by representing the interests of the state's technology industries in the Council's strategic planning and on-going operations.

# # #

About the Arizona Technology Council
The Arizona Technology Council is Arizona's premier trade association for science and technology companies. Recognized as having a diverse professional business community, Council members work towards furthering the advancement of technology in Arizona through leadership, education, legislation and social action. The Arizona Technology Council offers numerous events, educational forums and business conferences that bring together leaders, managers, employees and visionaries to make an impact on the technology industry. These interactions contribute to the Council's culture of growing member businesses and transforming technology in Arizona. To become a member or to learn more about the Arizona Technology Council, please visit

Media contact:
Linda Capcara
Global Connect Communications
[email protected]

About TGen
The Translational Genomics Research Institute (TGen) is a non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process.

Media Contact
Steve Yozwiak
Senior Science Writer
Translational Genomics Research Institute
(602) 343-8704
[email protected]

Media Contact

RSS Feed